Company Description
ZymoGenetics has proteins on its plate. The firm culls genomics databases to indentify and develop protein-based drugs targeting a variety...
Key ZymoGenetics Financials
| Company Type | Public - NASDAQ (GM): ZGEN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $38.5 |
| 2005 Employees | 468 |
More ZymoGenetics Financials (11 pages)
Latest ZymoGenetics Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about ZymoGenetics's competition across multiple industries
Top ZymoGenetics Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
ZymoGenetics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Bruce L. A. Carter | Network | E-mail |
| President and Chief Scientific Officer | Douglas E. (Doug) Williams | Network | E-mail |
| EVP, CFO, and Treasurer | James A. (Jim) Johnson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current ZymoGenetics News
- ZymoGenetics, Inc. (ZGEN) Corporate Event Announcement Notice [Wall Street Horizon] (01 Jul 2008 21:11:00 EDT)
- ZymoGenetics gains access to $100 million [Seattle Times (WA)] (01 Jul 2008 04:00:00 EDT)
- BioWorld Today July 1, 2008 [BioWorld Today] (01 Jul 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.